Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells

Acute myeloid leukemia (AML) is a polyclonal and heterogeneous hematological malignancy. Relapse and refractory after induction chemotherapy are still challenges for curing AML. Leukemia stem cells (LSCs), accepted to originate from hematopoietic stem/precursor cells, are the main root of leukemogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Jialan, Peng, Danyue, Liu, Lingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294245/
https://www.ncbi.nlm.nih.gov/pubmed/35865470
http://dx.doi.org/10.3389/fonc.2022.896426

Ejemplares similares

Ejemplares similares